KLINGENSTEIN PAUL H

Insider CIK 935463 · ETRM Director · CNAT Director, 10% owner · ANAC Director · CLVS Director

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
CLVS Clovis Oncology, Inc.	A Award deriv	2021-06-10	2021-06-11	42,223	—	$0	42,223	SEC↗
CLVS Clovis Oncology, Inc.	A Award deriv	2020-06-04	2020-06-05	40,138	—	$0	40,138	SEC↗
CLVS Clovis Oncology, Inc.	M Exercise deriv	2019-07-29	2019-07-31	25,862	—	$0	0	SEC↗
CLVS Clovis Oncology, Inc.	M Exercise	2019-07-29	2019-07-31	25,862	$0.29	$7.5K	59,327	SEC↗
CLVS Clovis Oncology, Inc.	A Award deriv	2019-06-06	2019-06-07	28,882	—	$0	28,882	SEC↗
CLVS Clovis Oncology, Inc.	A Award deriv	2018-10-11	2018-10-15	14,770	—	$0	14,770	SEC↗
CLVS Clovis Oncology, Inc.	A Award deriv	2017-06-08	2017-06-08	10,000	—	$0	10,000	SEC↗
CLVS Clovis Oncology, Inc.	A Award deriv	2016-06-09	2016-06-10	10,000	—	$0	10,000	SEC↗
CLVS Clovis Oncology, Inc.	A Award deriv	2015-06-11	2015-06-15	10,000	—	$0	10,000	SEC↗
CLVS Clovis Oncology, Inc.	A Award deriv	2014-06-12	2014-06-16	12,414	—	$0	12,414	SEC↗
ANAC Anacor Pharmaceuticals, In	A Award deriv	2014-05-29	2014-05-30	15,000	—	$0	15,000	SEC↗
CNAT Conatus Pharmaceuticals In	J Other	2014-02-19	2014-02-25	36,634	—	$0	36,634	SEC↗
CNAT Conatus Pharmaceuticals In	J Other	2014-02-19	2014-02-25	30,216	—	$0	22,203	SEC↗
CNAT Conatus Pharmaceuticals In	J Other	2014-02-19	2014-02-25	1,283,589	—	$0	943,355	SEC↗
CNAT Conatus Pharmaceuticals In	J Other	2014-02-19	2014-02-25	20,322	—	$0	20,322	SEC↗
CNAT Conatus Pharmaceuticals In	J Other	2014-02-19	2014-02-25	8,731	—	$0	8,731	SEC↗
CNAT Conatus Pharmaceuticals In	J Other	2014-02-19	2014-02-25	36,634	—	$0	0	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	5,701	—	$0	0	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	137,626	—	$0	0	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	73,395	—	$0	73,395	SEC↗
CNAT Conatus Pharmaceuticals In	X Exercise deriv	2013-07-30	2013-08-01	73,395	—	$0	0	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	42,336	—	$0	0	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	5,131	—	$0	5,131	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	246,775	—	$0	0	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	242,205	—	$0	0	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	363,308	—	$0	0	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	5,846,236	—	$0	0	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	10,483,166	—	$0	0	SEC↗
CNAT Conatus Pharmaceuticals In	A Award deriv	2013-07-30	2013-08-01	30,000	—	$0	30,000	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	120	—	$0	120	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	997	—	$0	0	SEC↗
CNAT Conatus Pharmaceuticals In	X Exercise deriv	2013-07-30	2013-08-01	1,727	—	$0	0	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	1,727	—	$0	1,727	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	8,552	—	$0	0	SEC↗
CNAT Conatus Pharmaceuticals In	S Sale	2013-07-30	2013-08-01	14	$11.00	$154	49,698	SEC↗
CNAT Conatus Pharmaceuticals In	X Exercise	2013-07-30	2013-08-01	1,727	$0.08	$138	49,712	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion	2013-07-30	2013-08-01	46,594	—	$0	47,985	SEC↗
CNAT Conatus Pharmaceuticals In	J Other	2013-07-30	2013-08-01	251	$11.00	$2.8K	49,949	SEC↗
CNAT Conatus Pharmaceuticals In	P Buy	2013-07-30	2013-08-01	2,470	$11.00	$27.2K	52,419	SEC↗
CNAT Conatus Pharmaceuticals In	P Buy	2013-07-30	2013-08-01	104,952	$11.00	$1.15M	2,226,944	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion	2013-07-30	2013-08-01	1,979,321	—	$0	2,038,535	SEC↗
CNAT Conatus Pharmaceuticals In	X Exercise	2013-07-30	2013-08-01	73,395	$0.08	$5.9K	2,111,930	SEC↗
CNAT Conatus Pharmaceuticals In	S Sale	2013-07-30	2013-08-01	552	$11.00	$6.1K	2,111,378	SEC↗
CNAT Conatus Pharmaceuticals In	J Other	2013-07-30	2013-08-01	10,614	$11.00	$116.8K	2,121,992	SEC↗
CLVS Clovis Oncology, Inc.	A Award deriv	2013-06-13	2013-06-17	12,414	—	$0	12,414	SEC↗
ANAC Anacor Pharmaceuticals, In	A Award deriv	2013-06-06	2013-06-07	15,000	—	$0	15,000	SEC↗
ETRM EnteroMedics Inc	A Award deriv	2013-05-08	2013-05-10	10,000	—	$0	10,000	SEC↗
CLVS Clovis Oncology, Inc.	A Award deriv	2012-06-14	2012-06-18	12,414	—	$0	12,414	SEC↗
ANAC Anacor Pharmaceuticals Inc	A Award deriv	2012-05-30	2012-06-01	12,500	—	$0	12,500	SEC↗
ETRM EnteroMedics Inc	A Award deriv	2012-05-09	2012-05-11	10,000	—	$0	10,000	SEC↗
CLVS Clovis Oncology, Inc.	C Conversion deriv	2011-11-21	2012-03-22	10,122	—	$0	0	SEC↗
CLVS Clovis Oncology, Inc.	C Conversion deriv	2011-11-21	2012-03-22	507,119	—	$0	0	SEC↗
CLVS Clovis Oncology, Inc.	C Conversion deriv	2011-11-21	2012-03-22	10,122	—	$0	0	SEC↗
CLVS Clovis Oncology, Inc.	C Conversion deriv	2011-11-21	2012-03-22	1,097,661	—	$0	0	SEC↗
CLVS Clovis Oncology, Inc.	C Conversion deriv	2011-11-21	2012-03-22	507,119	—	$0	0	SEC↗
CLVS Clovis Oncology, Inc.	C Conversion deriv	2011-11-21	2012-03-22	0	—	$0	0	SEC↗
CLVS Clovis Oncology, Inc.	C Conversion deriv	2011-11-21	2012-03-22	0	—	$0	0	SEC↗
CLVS Clovis Oncology, Inc.	C Conversion deriv	2011-11-21	2012-03-22	21,909	—	$0	0	SEC↗
CLVS Clovis Oncology, Inc.	C Conversion	2011-11-21	2012-03-22	728,239	—	$0	728,239	SEC↗
CLVS Clovis Oncology, Inc.	C Conversion	2011-11-21	2012-03-22	14,534	—	$0	14,534	SEC↗
CLVS Clovis Oncology, Inc.	C Conversion	2011-11-21	2012-03-22	158,439	—	$0	886,678	SEC↗
CLVS Clovis Oncology, Inc.	C Conversion	2011-11-21	2012-03-22	3,162	—	$0	17,696	SEC↗
CLVS Clovis Oncology, Inc.	P Buy	2011-11-21	2012-03-22	391,478	$13.00	$5.09M	1,278,156	SEC↗
CLVS Clovis Oncology, Inc.	P Buy	2011-11-21	2012-03-22	7,813	$13.00	$101.6K	25,509	SEC↗